1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On May 07, 2026, at 1:15 PM, Licensing Program Analyst (LPA) Avelina Martinez made an unannounced visit to this facility to conduct an annual required inspection. LPA Martinez met with Kevin Valino and Aly Ramirez and explained the purpose of today's visit.
LPA Martinez conducted a continuation annual inspection to review Medication Administration Records (MAR) for three residents. Resident 1 (R1) Centrally Stored Medication and destruction record was not complete. Resident 3 (R3) Centrally Stored Medication and destruction record had three entries for Famotidine Tab 20 mg with the same RX number, and the three entries had different start dates, expiration dates, and filled dates. R3's had two medication bottles for Venlafaxine ER 1500MG Capsules. One bottle start date was February 23, 2026, with a quantity of 90 pills, and as of May 07, 2026, there are 47 pills left in bottle. The second bottle start date is April 30, 2026 with a quantity of 15 pills, and as of May 07, 2026, there are 14 pills left in the bottle.
Based on this annual inspection, the facility was cited incidental 87465 (a)(4) Incidental Medical and Dental Care and 87465 (a)(6) Incidental Medical and Dental Care.
An exit interview was conducted, and a copy of this 809 report, 809 D Page, and Appeals rights were provided to the facility.
|